{
  "id": 100,
  "university": "JNTHU",
  "regulation": "R25",
  "course": "B.Pharm",
  "effective_year": "2025",
  "curriculum_type": "university",
  "curriculum_data": {
    "years": [
      {
        "year": 4,
        "semesters": [
          {
            "semester": 1,
            "subjects": [
              {
                "code": "PS707",
                "name": "PHARMACOVIGILANCE (Open Elective - III)",
                "type": "theory",
                "category": "elective",
                "units": [
                  {
                    "number": "Unit I",
                    "title": "Introduction to Pharmacovigilance and Adverse Drug Reactions",
                    "topics": [
                      "History of Pharmacovigilance",
                      "Development of Pharmacovigilance",
                      "Importance of safety monitoring of Medicine",
                      "WHO international drug monitoring programme",
                      "Pharmacovigilance Program of India (PvPI)",
                      "Definitions of ADRs",
                      "Classification of ADRs",
                      "Detection of ADRs",
                      "Reporting of ADRs",
                      "Methods in Causality assessment",
                      "Severity assessment of ADRs",
                      "Seriousness assessment of ADRs",
                      "Predictability assessment of ADRs",
                      "Preventability assessment of ADRs",
                      "Terminologies of adverse medication related events",
                      "Regulatory terminologies"
                    ]
                  },
                  {
                    "number": "Unit II",
                    "title": "Drug and Disease Classification and Pharmacovigilance Programme",
                    "topics": [
                      "Anatomical classification of drugs",
                      "Therapeutic classification of drugs",
                      "Chemical classification of drugs",
                      "International classification of diseases",
                      "Daily defined doses",
                      "WHO adverse reaction terminologies",
                      "MedDRA",
                      "Standardized MedDRA queries",
                      "WHO drug dictionary",
                      "Basic drug information resources",
                      "Establishing pharmacovigilance in a hospital",
                      "Establishment of drug safety department in industry",
                      "Operation of drug safety department in industry",
                      "Contract Research Organizations (CROs)"
                    ]
                  },
                  {
                    "number": "Unit III",
                    "title": "Vaccine Safety Surveillance and Pharmacovigilance Methods",
                    "topics": [
                      "Vaccine Pharmacovigilance",
                      "Vaccination failure",
                      "Adverse events following immunization",
                      "Passive surveillance",
                      "Spontaneous reports",
                      "Case series",
                      "Stimulated reporting",
                      "Active surveillance",
                      "Sentinel sites",
                      "Drug event monitoring",
                      "Registries",
                      "Comparative observational studies",
                      "Cross sectional study",
                      "Case control study",
                      "Cohort study",
                      "Targeted clinical investigations"
                    ]
                  },
                  {
                    "number": "Unit IV",
                    "title": "Safety Data Generation and ICH Guidelines",
                    "topics": [
                      "Statistical methods for evaluating medication safety data",
                      "Safety data generation in pre-clinical phase",
                      "Safety data generation in clinical phase",
                      "Safety data generation in post approval phase",
                      "Organization of ICH",
                      "Objectives of ICH",
                      "Expedited reporting",
                      "Individual case safety reports",
                      "Periodic safety update reports",
                      "Post approval expedited reporting",
                      "Pharmacovigilance planning",
                      "Good clinical practice in pharmacovigilance studies"
                    ]
                  },
                  {
                    "number": "Unit V",
                    "title": "Pharmacogenomics and Special Population",
                    "topics": [
                      "Pharmacogenomics of adverse drug reactions",
                      "Drug safety evaluation in pediatrics",
                      "Drug safety evaluation in pregnancy",
                      "Drug safety evaluation in lactation",
                      "Drug safety evaluation in geriatrics"
                    ]
                  }
                ]
              },
              {
                "code": "PS708",
                "name": "QUALITY CONTROL AND STANDARDIZATION OF HERBALS (Open Elective - III)",
                "type": "theory",
                "category": "elective",
                "units": [
                  {
                    "number": "Unit I",
                    "title": "Basic Tests and Guidelines for Herbal Drugs",
                    "topics": [
                      "Basic tests for pharmaceutical substances",
                      "Basic tests for medicinal plants materials",
                      "Basic tests for dosage forms",
                      "WHO guidelines for quality control of herbal drugs",
                      "Evaluation of commercial crude drugs"
                    ]
                  },
                  {
                    "number": "Unit II",
                    "title": "Quality Assurance in Herbal Drug Industry",
                    "topics": [
                      "Quality assurance in herbal drug industry",
                      "cGMP in traditional system of medicine",
                      "GAP in traditional system of medicine",
                      "GMP in traditional system of medicine",
                      "GLP in traditional system of medicine",
                      "WHO Guidelines on cGMP for Herbal Medicines",
                      "WHO Guidelines on GACP for Medicinal Plants"
                    ]
                  },
                  {
                    "number": "Unit III",
                    "title": "EU and ICH Guidelines",
                    "topics": [
                      "EU guidelines for quality control of herbal drugs",
                      "ICH guidelines for quality control of herbal drugs",
                      "Research Guidelines for Evaluating Safety of Herbal Medicines",
                      "Research Guidelines for Evaluating Efficacy of Herbal Medicines"
                    ]
                  },
                  {
                    "number": "Unit IV",
                    "title": "Stability Testing and Chromatographic Techniques",
                    "topics": [
                      "Stability testing of herbal medicines",
                      "Application of chromatographic techniques in standardization",
                      "Preparation of documents for new drug application",
                      "Preparation of documents for export registration",
                      "GMP requirements",
                      "Drugs & Cosmetics Act provisions"
                    ]
                  },
                  {
                    "number": "Unit V",
                    "title": "Regulatory Requirements and Safety Monitoring",
                    "topics": [
                      "Regulatory requirements for herbal medicines",
                      "WHO guidelines on safety monitoring of herbal medicines",
                      "Comparison of Herbal Pharmacopoeias",
                      "Role of chemical markers in standardization",
                      "Role of biological markers in standardization"
                    ]
                  }
                ]
              }
            ]
          }
        ]
      }
    ],
    "university": "JNTHU",
    "regulation": "R25",
    "course": "B.Pharm"
  },
  "stats": {
    "years": 4,
    "semesters": 1,
    "subjects": 2,
    "units": 10,
    "topics": 90,
    "theory": 0,
    "practical": 0,
    "electives": 2
  },
  "status": "active",
  "created_at": "2025-12-16T07:46:22.238572+00:00",
  "updated_at": null
}